Teresa Bitetti – General Manager, BMS Canada
Teresa Bitetti has a long history with BMS, spanning 3 decades in which she rose up the ranks starting from Senior Director of Abilify Marketing before becoming Sales Vice President…
We combine world-leading expertise in antibody generation and disease biology to create superior therapeutic antibodies. Our therapeutic antibody candidates are derived from a state-of-the-art phage display platform developed and refined by world-leading researchers at the University of Toronto, and we focus on developing novel functional modulators of key signalling pathways in cancer and fibrosis.
While most immuno-oncology products in the clinic target the immunosuppressive factors that help tumors evade an attack, Northern Biologics Inc.’s anti-LIF antibody takes a step further.
By simultaneously blocking both immunosuppression and self renewal of cancer stem cells the newco expects the antibody to be effective against a wider range of cancers than other immune oncology programs.
Contact:
Address: 101 College Street TMDT 11-301, Toronto, ON M5G 1L7 Canada
Tel.: +1 416-634-7132
Website: http://northernbiologics.com/
Email: info@northernbiologics.com
Teresa Bitetti has a long history with BMS, spanning 3 decades in which she rose up the ranks starting from Senior Director of Abilify Marketing before becoming Sales Vice President…
Mike Brogan, before taking up the mantle of President at IMS was VP of Business Integration at IMS for a year. Today, he talks about the difficulties he has come…
Dr. Fernand Labrie, long before becoming CEO of EndoCeutics, discovered and developed medical castration with GnRH agonists, a breakthrough treatment that quickly replaced surgical castration back in the early 1980s.…
Minister for Science shares with us how the Canadian Government has taken a different approach to funding innovationand the benefits it has reaped in the pharma industry as a whole…
Gary Goodyear, Minister for Science, shares with us how the Canadian Government has taken a different approach to funding innovation and the benefits it has reaped in the pharma industry…
You have been President of Rx&D since 2004, and have witnessed the market’s development over the years. What have been the most important issues since you started and what are…
See our Cookie Privacy Policy Here
